| dc.contributor.author | Boyers, Dwayne | |
| dc.contributor.author | Jia, Xueli | |
| dc.contributor.author | Crowther, M | |
| dc.contributor.author | Jenkinson, David James | |
| dc.contributor.author | Fraser, Cynthia Mary | |
| dc.contributor.author | Mowatt, Graham | |
| dc.date.accessioned | 2012-03-23T11:49:02Z | |
| dc.date.available | 2012-03-23T11:49:02Z | |
| dc.date.issued | 2008-12 | |
| dc.identifier | 3436968 | |
| dc.identifier | fec25360-4705-4446-ba06-8646f65ff129 | |
| dc.identifier.citation | Boyers , D , Jia , X , Crowther , M , Jenkinson , D J , Fraser , C M & Mowatt , G 2008 , Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal . NIHR Health Technology Assessment programme , Southampton, United Kingdom . < http://www.hta.ac.uk/erg/reports/2163.pdf > | en |
| dc.identifier.uri | http://hdl.handle.net/2164/2320 | |
| dc.description | Evidence Review Group (ERG) final report for the National Institute for Health and Clinical Excellence | en |
| dc.format.extent | 164 | |
| dc.format.extent | 2554248 | |
| dc.language.iso | eng | |
| dc.publisher | NIHR Health Technology Assessment programme | |
| dc.subject | RA Public aspects of medicine | en |
| dc.subject.lcc | RA | en |
| dc.title | Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura : A Single Technology Appraisal | en |
| dc.type | Report | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.identifier.url | http://www.hta.ac.uk/erg/reports/2163.pdf | en |
